Skip to main content
. Author manuscript; available in PMC: 2021 Jul 28.
Published in final edited form as: Ann Surg Oncol. 2020 Jun 2;27(11):4122–4130. doi: 10.1245/s10434-020-08648-7

FIG. 2.

FIG. 2

Examples of treatment response for two responders treated with neoadjuvant immunotherapy. a A patient with inguinal lymph node disease and a Tex frequency of 6.5% (as shown in the flow cytometry plot) who responded to anti-PD-1/CTLA-4 combination immunotherapy. b A patient with axillary lymph node disease and a Tex of 34.4% who responded to anti-PD-1 monotherapy. In both panels, the pre- and posttreatment imaging (computed tomography) and histology are shown, demonstrating marked radiographic and histologic responses. The red arrows mark the radiographic response